Focused on solving unmet needs in ophthalmology

Addressing significant unmet medical needs for better topical therapy
image/svg+xml TABLEAU_OCULIS modif 2020-03-04T16:01:12+01:00 2020-03-04T16:01:12+01:00 2020-03-04T16:01:12+01:00 Adobe Illustrator 24.0 (Macintosh) 256 100 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgAZAEAAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A9U4q7FXYq7FXYqtmjWWJ 4mqFdSpI60IpirFH/LXR/qZsob3ULa0MZiMEVxROLKitsyt19OvhVj7UlxIpExeR7SMljqWoSMYn hV3mUsqyKVJU8Kgjl19h71FpUp/y9sJ4pIptT1F0kf1HUzrxPxF+PHhx4gnYU2x4kUpN+Wumlyw1 XU1ryNEuFWjMGXltGDyo9K4eJaZai8EValuIA5Mak07k5FKTaz5VtdVvY7uS8vLWRI/S42s3pKwq SC1ASSpbbfCCqU3X5bWksUoi1fUUndCkUskwl9Pk/OqgqDWtO/bDxIpVg/LyzjcTHVdRNxRQ8qzB agSGXiPhJC8jSlenvvjxLS7/AJV7YH1+ep6jIZkEas86sYgJY5h6R4VU8oV+jBxLTn/L3T2d5BqW orK6lDKJl58TH6dORQnbqK9DvjxLTcH5f6fAZPS1LUU9UyMwWcL8cpDc/hQfEpUUJ+muNppG+WvK 0GhCYRXU1z6yRIfWIPERFyAlAKL+82XsMSbVV1XQbPW9PtYbl5YhARNDJCwR1kMLxBgSDuolJHvT EFUtk8gWTGIrqupxvCpUOtzUsSa8n5K3Ij3xtFLLj8utOml9X9J6jG4JKFJ0HDknA8P3e23398PE tJ5aadHp2nSwJNNOlGblO/qNuu+9O5FfmcilVvbGHUNKuLCcsILyB4JSho3CVCjUJB3ocVSBfy80 2IKlrqOo2tujs8dvDOBGvKQScRVGNPhp16e++HiRScaRolvpakRTTTs0ccTSXDiRyIuXElqAk/Hv iSlFxn/Sph7J/HArH9Q8gaVeX01+l1eWd3cGQzS2soQsJVRCu6sKD0hT3w2il9v5GsIlYSX99c8p UmBnmElGjLkBRxoAfV327D3q2lPbs0iX/jJF/wAnFwKlWr+UdM1PUF1GWSeC+SNYY7iCTgyohc0A oRuZTWowgqg4PINjErK+p6jcKyCNlnuA60BjIPHhSv7kfecbRScafplvpenW1hbs7QwNRGkILHkx bcgKO/hgSlPmLzzZaHqEVpcWk8gcx85kC0CyCQ8lWvJ+PomtBtUYQLRaCvPzR0a1tppntLslAfST 0wObcGcL12NUKnrTbxw8K2q3v5l6HYT3cV5BcxfVJngZwiMHKBySlGqR+7322qK0O2PCtpz5e8xW GvWb3lisghR/TPqrwJPFXqNzUUcb/wAMBFJV9cvpNP0XUL+JPVltLaadI/5mijLhfpIwwFkBhklw xJ7g+RtT8x67qd5JeX19PPcSklmZ2oPZRWigdgM3sccQKAeOnqMkjZJT608sXU9paXDa2QLlVYxx 8pZE58Pi4K/IovqUYjcMCKHrlJygEinOhppEA8fP8d6he+U54ba7uZtWiaS2eZFj5rI0no1IAaN5 FDELUiu1Rua5KOUWBTXPSGiTLlf2fFjiXd2gok0ijwViB+By7hDhDJIciV31++/5aZf+Db+uPCO5 Piz7yjdDvr061p4NxIQbmEEF2/34PfITiOEtuDLLxI7nmGY635W1HU9f1q+TWrezibWL2AwTzMjo iTMWl4j9hV65jwyCMQKvYOfPTznKUuOhxS6+aGl8g6rBHA0/mG1VpxH8CzSPweSlEcqKKfi7/PD4 8f5qPyMwN5/ehrTyZq1y9yo122jW1ZFkkknZQwcIS6d2RVflXwGE5oj+FjHSTN+vl5un8la7EGVN XhlnVCzQpOSeYUOEBrQk1I8Kqw7YjNHuU6PJ/P396Ik8g6vHcW8P+ILWQXMcsqyRTu6qsUixryI/ n58h7A16YPHjX0p/JZLA4+d9W1/L7WGVmXzDaEIQGP1hwKGR46gnqF4VanQY+PH+an8jk/n/AGsR v31Gyvri0e7d2t5GjLpIzI3E05KQdweozIiARdOvySnGRjZ281D6/ff8tEv/AAbf1yXCO5h4s+8u +v33/LTL/wAG39ceEdy+LPvLvr99/wAtMv8Awbf1x4R3L4s+8u+v33/LRL/wbf1x4R3L4s+8u+v3 3/LRL/wbf1x4R3L4s+8u+v33/LTL/wAG39ceEdy+LPvLvr99/wAtMv8Awbf1x4R3L4s+8u+v33/L RL/wbf1x4R3L4s+8u+v33/LTL/wbf1x4R3L4s+8vr3yuSfLWkkmpNlbkk/8AGJc0OT6j73s8X0j3 I66r6S0/35H/AMnFyDNVxV2Kqc37H+uMVVMVdiq2SOOSNo5FDxuCrowBBB6gg4q2iIiKiKFRQFVV FAANgABirmClSGAKkUYHpT3xV82+ZtO/JtNZuRZ6lfpFzNY7SJJoFau4jdyhK+HX55t8cs1bgPN5 8ek4jUj8OSVfUfyp/wCrpq3/AEiw/wDVTJ8WXuDTwaX+dL5Ieaz/AC1D0i1PVin/ADBwH8TcJ+rC Dl7h82Eo6boZ/IKkFl+WBQ+tqmrBq7f6JAu30TP+vEnL3BlGGm6yl8lT6j+VP/V01b/pFh/6qYOL L3BPBpf50vki9JsvyvGq2Rh1PVWmE8Xpq1tCFLcxQEh+lcjOWWjsGzFDTcYqUrsIrzZZ/lo3mnWW vNS1SO7N9cm4SO3hZFkMzcwpLglQ3TBjll4RQHJlnhpvElcpXZSr6j+VP/V01b/pFh/6qZPiy9wa eDS/zpfJ31H8qf8Aq6at/wBIsP8A1Ux4svcF4NL/ADpfJ31H8qf+rpq3/SLD/wBVMeLL3BeDS/zp fJ31H8qf+rpq3/SLD/1Ux4svcF4NL/Ol8nfUfyp/6umrf9IsP/VTHiy9wXg0v86Xyd9R/Kn/AKum rf8ASLD/ANVMeLL3BeDS/wA6Xyctj+VfEctU1blTeltDSv8AyMx4svcF4NL/ADpfJ31H8qf+rpq3 /SLD/wBVMeLL3BeDS/zpfJ31H8qf+rpq3/SLD/1Ux4svcF4NL/Ol8nNY/lXxPHVNW5U2rbQ0r/yM x4svcF4NL/Ol8nCx/Kqm+qatXv8A6ND/ANVMeLL3BeDS/wA6Xyd9R/Kn/q6at/0iw/8AVTHiy9wX g0v86Xyd9R/Kn/q6at/0iw/9VMeLL3BeDS/zpfJoWP5V8jXVNW47U/0aGvv+3jxZe4LwaX+dL5N/ Ufyp/wCrpq3/AEiw/wDVTHiy9wXg0v8AOl8n0z5fFuNB00WzM9uLWAQs4AYp6a8SwFaGnXNPPmXp 8dcIruRN3X0lp/vyL/k4uRZq2KuxVTm/Y/1xiqpirsVdirsVQOu2lze6JqFnav6dzc200MEnTi8k ZVW+gnJQNEEsMkSYkDnT48vbK7sbuW0vIXguYGKSwyAqysOxBzfggiw8VOBiaOxDI7LzN5dhtbSJ 9IjM0KoJpmjhl58THyQq6gkScGYsW5DlxBAGUyxys7udDU4gADH7B5ff81O58w+XJLS6ih0dY5Z2 nMcremxjEleBUqqUoeOwFFp8I3OIxysbolqMRiQIbm+5jOXuA7FUdoX/AB29P/5iYf8Ak4MjP6S2 4P7yPvDM9a806HpvmHzBa3fl631G6Gr3kqXkrAEfv3AQqUbkvsTmNDFIxBEq2Dn5NTCE5AwEjxHf 4+5L9P8AOXlS3q1x5Ugu3J5nlMFXn+7OyiH7NYfs/wCUw75M4Zn+Jrjq8Q/yY+f7F03nXywQ5t/K ltC7JRWMiygNST4uLwkdZq0/yVHbHwZfzknWY+mMfj4LLzzh5UuIpI18qQQiT0/jjmAdeDln4kRC nNW4+3XtTEYZj+JEtXiP+TH4+DV/5x8s3NjcQQ+Vre2uJklVLhJR8DSHkrBfS/3WSePEjag6Ddjh kD9Sz1eMxIGMC/x3Kv8Ajfys06yP5RtOPqSNJGkvFWRxxVRWNuJUUII25VNKGgHgy/nFP53H/qcf x8EEvmnQDYtbS+XoTIYmiS4jdUcFkZQ5/dNV1ZuQP0GtARLwpXfEw/NYyK4B+PgiovOflaNCo8qW 7tymdWklDUaSQunSIVWNSV49Dt0pgOGX85mNZiH+TH4+DWoecfK91E6xeVba2dmgIeOX9mGQNItP TH96q8Txp4+NWOGQ/iRPV4yNsYHL8curUnnDys1KeWIlANaCWPcnkKk+h3V+g+GoBAG4L4Mv534+ afzmL/Ux9n6lg82eWFjsUTyzCDaujTu0ys0ypCYiG5QkfESHOxHIdMPhS39TH81j2/djb7dq7vir J5z8qqjKfKkDEs7RuZVqvqbkf3NGC/s16D33weDL+cy/OYv9TH4+CB17zTpGo2TwWegW2nTSMpNx GQSFDMxCgIlOVVFfBadzkoYiDvK2rPqYTjQgI/j3Mby5w3Yq7FX2L5W/5RjSP+YK3/5NLmgyfUfe 9ti+ge5G3YBiX/jJF/ycXINitirsVU5v2P8AXGKqmKuxV2KuxVD6hfQWFhc31waQWkTzzEdQkalm /AYYizTGUhEEnkHzbrP5z+adRv5LiOGzghO0ULW0UxVB0BeVWYn/ADpm3jpIgdXmsnauQmwAAirf zP8AmZcRQyxWliUuOPolraxXk0nHglGAPNxIpVepBBApkTjxDqftbo6jUkAgR39yFn178w5lnuWt LHhbiT1W+p6c20AJcryRiwojEFa1ANOhwiGPlZ+Za5ZtSbNDbyj0S2D8zvNEKcEFjStf94LRf+Ix qMsOmj5/Npj2jlHd8gqf8rV81+Fj/wBIVt/zRg/Kw8/mn+U8vl8kXpP5n+aJtVsoXFlwkniRqWVs DRnANCE2yM9NEA8/m2Yu0ckpgGtyOic6/wCbfP58xazHp1lBPZ21/cwRyCxgk2SZkXk5QknbcnK4 YsfCLO9d7fk1Oo45cIsCRHLzQbeZ/wA0lBLaXCOIct/uPtthGKuT8H7I65Lw8Xf9rHx9V/NHyCT/ APK1fNfhY/8ASFbf80ZZ+Vh5/Nxv5Ty+Xyd/ytXzX4WP/SFbf80Y/lYefzX+U8vl8nf8rV81+Fj/ ANIVt/zRj+Vh5/Nf5Ty+Xyd/ytXzX4WP/SFbf80Y/lYefzX+U8vl8nf8rV81+Fj/ANIVt/zRj+Vh 5/Nf5Ty+Xycv5p+alUKBZUAoP9Ctv+aMfysPP5r/ACnl8vk7/lavmvwsf+kK2/5ox/Kw8/mv8p5f L5O/5Wr5r8LH/pCtv+aMfysPP5r/ACnl8vk5vzT81MpUiyoRQ/6Fbf8ANGP5WHn81/lPL5fJw/NT zWBSllt/y5W3/NGP5WHn81/lPL5fJ3/K1fNfhY/9IVt/zRj+Vh5/Nf5Ty+Xyd/ytXzX4WP8A0hW3 /NGP5WHn81/lPL5fJofmn5qDFqWVTSv+hW3b/YY/lYefzX+U8vl8m/8Alavmvwsf+kK2/wCaMfys PP5r/KeXy+T6Z8v3ElxoOm3ElPUmtYJH4gKOTRqTQDYDfpmnmKJenxm4g+SJu+PpLyFR6kX3+otM izVsVdiqnNT4K/zjFVTFXYq7FXYqo3lpBeWc9pcLyguY3ilXpVHUqw+44QaNokARRfN/mD8ndT03 U5baDVdNeAGsX1i6jgm4H7PON6UPy2zbQ1YI5F5rL2XKMqEo15luPyp51jhigXXtMMMICxxNf27K AKU+FqjbgoHsAOmA5Ydx+TZHT5wABONDzUrjSPPCJcWsuv6dLFdB/rCvqVo3MS7tX1H5df7MIlDn wn5FjLHnAIM47/0glsH5b6vMnJdR0kb0p+kLY/8AEWYZYdQB0PyaI9nzP8Ufmqf8qw1n/q5aT/0n wf1wfmY9x+Sf5Nn/ADo/NF6T+Wurw6rZStqOlMsc8TlVvoSxCuDsAdzkZ6gEHY/JsxdnzEwbjsR1 TrX/ACz5wTzDrJsNcsLW0uNQvJ1t2v4oyPXZ0bmhOzem5Ug5XDJDhFg8h0b8mnzCcuGcQDInn3oO TQPP8khkbzHp3MhwWGoW4/vAA/Tx4jDx4/5p+SDi1H8+Pz/Yk3/KsNZ/6uWk/wDSfB/XLfzMe4/J xf5Nn/Oj83f8qw1n/q5aT/0nwf1x/Mx7j8l/k2f86Pzd/wAqw1n/AKuWk/8ASfB/XH8zHuPyX+TZ /wA6Pzd/yrDWf+rlpP8A0nwf1x/Mx7j8l/k2f86Pzd/yrDWf+rlpP/SfB/XH8zHuPyX+TZ/zo/Ny /ljrBUH9JaSKitDfwg/rx/Mx7j8l/k2f86Pzd/yrDWf+rlpP/SfB/XH8zHuPyX+TZ/zo/N3/ACrD Wf8Aq5aT/wBJ8H9cfzMe4/Jf5Nn/ADo/NzfljrAUn9JaSaCtBfwk/rx/Mx7j8l/k2f8AOj83D8sd ZIr+ktJ3/wCX+D+uP5mPcfkv8mz/AJ0fm7/lWGs/9XLSf+k+D+uP5mPcfkv8mz/nR+bv+VYaz/1c tJ/6T4P64/mY9x+S/wAmz/nR+bQ/LLWCxX9JaTtTf6/DTf6cfzMe4/Jf5Nn/ADo/Nv8A5VhrP/Vy 0n/pPg/rj+Zj3H5L/Js/50fm+mfL8DW+g6bAzKzQ2sEbMhDKSsaiqsNiPA5p5myXp8YqIHkibo/u l2r+8j/5OLkWatirsVU5v2P9cYqqYq7FXYq7FUDrs95BomoT2K8r2K2me1XrWVYyUH/BUyUACRbD ISImudPjmeeaeZ553aWaVi8kjkszMxqSSdySc6ACniZSJNlk1no3k2S0tJJtRk9eQJ9ZiEiR8Q3p 82HNKAoWdQhb4uPLkAcolOdnZz4YMJiCZb+/9n2O/QXlL6lqEo1UPPB9YNrEsgHPhX0gOcSc6/DX 7PKpp9mjPiTsbL4GHhJ4txdb/LoxXL3XuxVHaF/x29P/AOYmH/k4MjP6S24P7yPvDMte0Hyvd695 gu9Q1wWV7+ldQUWQj5MVSR2RuVQByei7/wAMxoZJiIAFig7DJgxSnIylR4pbfFLrfy35LkeQSa+y Itw8MbmNByjV40ElC+wbmzj/ACV8cmck/wCa1x02A/x9fJilwkaTyJG3ONWZUfxANAdvHLxycCYA JAU8LF2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV9i+Vv+UY0j/mCt/+TS5oMn1H3vbYvoHuRt3X0lp/ vyL/AJOLkGxWxV2Kqc37H+uMVXVl/lX/AII/0xV1Zf5V/wCCP9MVdWX+Vf8Agj/TFXVl/lX/AII/ 0xV1Zf5V/wCCP9MVeXeY/J/5PzarNLetHbXbMTPHazSBOZ61VFZVPiBTMuGfKBs6/LosEpWRulf+ CfyU/wCWqT/kdP8A9U8n+YzMP5P0/d9pUZvJH5K89tQuU/yUeUj7zA2EajKxPZ+n818Pkn8lQm97 M+/V5ZlP3CFcB1GZI7P0/wCCV/8Agn8lP+WqT/kdP/1Tx/MZk/yfp+77Sr2Xk38m47yCS3uZDOki NCDNN9sMCvWPxwHPlpMdDpwQQN/eVbWvKH5RXGs38+oXLrfy3Er3aiWYATM5MgAEdPtVwRz5QABy TPQ4JSJI3PmUF/gn8lP+WqT/AJHT/wDVPJfmMzH+T9P3faXf4J/JT/lqk/5HT/8AVPH8xmX+T9P3 faXf4J/JT/lqk/5HT/8AVPH8xmX+T9P3faXf4J/JT/lqk/5HT/8AVPH8xmX+T9P3faXf4J/JT/lq k/5HT/8AVPH8xmX+T9P3faXf4J/JT/lqk/5HT/8AVPH8xmX+T9P3faWo/JP5LcF53UnKg5fvp+vf /deP5jMv8n6fu+0t/wCCfyU/5apP+R0//VPH8xmX+T9P3faU20v8n/yz1S2NzYLNPAGKFxcSD4hQ kfEg8cgdXkHNkOzMB5D7SiZfyL8irE7C3nqqkj/SG7D/AFcH5zIn+S8Hd9pbT8ivIpRSbeepAP8A vS3/ADTj+cyL/JeDu+0rv+VE+RP+Wef/AKSW/wCacfzmRf5Lwd32l3/KifIn/LPP/wBJLf8ANOP5 zIv8l4O77Spp+RnkYzSIbeeihSP9IbvX/Jx/OZF/kvB3faVT/lRPkT/lnn/6SW/5px/OZF/kvB3f aWeWVqLOzgtIUAhto0iiBYk8UUKtTTwGYxNm3PAoU3dGb0l2A/eR78j/AL8X2wJVqy/yr/wR/pir qy/yr/wR/piqnKZax1AA5itD/ZiqT6tN5zjv5G0u3tZ7ERjgkxKyGTg7HcMBTkqLv/NXthFKgprr 8wzcF47K2SOiFIQ6uu4XkGcsjcuXKoC0ApRmx2VTg1H8yXNsk2lW0SyMDcyLMjGJSzEgfF8RAoOn 49DshSvNZ/MuzjkkXRre8UFyAjAMBycRgKsjFtuBO3Tv4NBU7hm8w3Pl68a6t1tdVaOdbeONqivE +ka1ah6d8RVqeTwNgwYhgQwNGB6171zOcFnFi2rSafbhbex9KKK2IkkEqNvwMbs1AH4FAX4kgbg5 SatvF0rWOneZ7d09EWsbyPcvGknqv6bsoDgLwYNxK1AUHc74CYqBJLtR0PV7uKKCQ2sFXMqhWdqv JGzEVVWH2IOXXuPHJCQCJRJY3qWnT6fdG2mZWcKr8krSjqGH2gp6HLAbapCmtM/46Vp/xmj/AOJD E8ljzZHqi+Vf0vqzai1x9dF/dfBHshT1Tx3od+uVjioU2Hhs2hY4/IrMhklvEBQc1UK1H8Kmm30Y fUj0KMEXlAQqJ5rgzj1ebIPgNCfSIBFelK/wwniQOFE+n5Ar/e3oUf6ta0WlPh8eVfb3wepPoQes J5WFvXSpLhp+SiktONPi5EbD/Jp9OGPF1RLh6JNk2t2KuxV2KvYvym/5RZ/+YmT/AIimYmb6nLw/ SzC5p9Xlr04N+rKm1dH/AHa/IfqxVdirsVUY6fWpvGifxxVWxV2KqN3T0lrt+8i/5OLiqtirsVU5 v2P9cYqqYq7FXYq7FVk80UEMk8rcYolLyMeyqKk/dirxjXfOWkahqElwmg2rKx/vJTIJH/yn9JkF T9PzzLjjIHNxZZATyRkenyyW0Nyvl/TzFMqPGfUuSeMhTcgSbBfUBb6cF+ZTXkEPBYpdyHhpGmRc WlST1ZbxAhgAZyx9VVpRga4brqUcN9Ahrqa3sLdZbjQrAhpGiAElyWqgBJo0pNPi64Rv1QdugQh8 w6WeugWf/BXH/VXDwnvRxjuV9P17TGv7ZRoVmhMqAMGuKirDcVkwGJrmkSF8kVr2s2C69qUZ0K1n dLqdWlYz8nKyNVjxkAqeppgjE0N0ykLOyA/Ten1p/h20r4Vue/8Az0yXCe9jxDubGtWBpTy7aGvS hue3X/dmPCe9eIdzQ1vTz08u2h+m59/+LPbHhPevEO5sa1YHp5dtD8jc/wDVT3x4T3rxDuWnXdOA qfL1oB4lrj/qpjwnvXiHc1/iDSv+rBZf8Fcf9VceE968Y7mhr+lgAfoGzNO/K4/6qY8J714x3N/4 g0r/AKsFl/wVx/1Vx4T3rxjueofltdwXXl5pYbSOzT6w6+jCXK1Crv8AGzGv05jZRRcjEbDJrj/e eX/Ub9WVti6P+7X5D9WKrsVdiqjH/vTN8k/jiqtirsVUbr+6X/jJH/ycXFVbFXYqpzfsf64xVUxV 2KuxV2KqN9aR3llcWkhIjuYnicjrxdSp/XhBpBFvENR8g+abK5eIWMlygJCTQDmrDsdtx9OZYyRL iHFIJnbaBIluon0DUJJgkQoqyIOS/wB6GPqGok6CijiPHImXmGYj5K40ayR4xJ5e1SQD1BIximJY EUTlxmAPvQr9OPEe8J4R3FYdDhf06eXNTaIUEgkWTlsj1Knmo+0yD7PRfemPF5hHD5FKNS8qazJd FrDRruK3KrRHjeobiOXUvty98kJjqWEoHoFun+U/MyX9s76XcqiyoWYxtQAMCT0wmYrmogb5J5qU PneDUdUgsrCd7Ge9uZ1IhLBvUZl5BvDiaimQHDQtmeIE0orL+YayGVdLkWU8KuLY1pGQUXwoGUN8 xj6O9bn3OWb8xktjbpp0yx1ciluagyElqE1O9cfR3rc+5UgvPzGt0ZIdKeNWJNBbHavImhNT1dj/ ALI41DvW59y2W5/MiRuTabKKUIC23EDiVPYDY+mgp4AY1DvW59yG1OH8wNStmtrvTZ2idxKaQEEM o47EDavfCOEdUS4z0Sj/AAh5p/6tVz/yKb+mT4497Dw5dzh5R80EAjS7kg7g+m39MeOPevhy7nf4 Q80/9Wq5/wCRTf0x4496+HLueqflpp99YeXWgvYHt5jcOwjkUq3EqtDQ/LMbKQTs5OIEBk9xX6vL Trwan3ZU2Lo/7tfkP1YquxV2KqMdfrM3hRKfjiqtirsVUrqvpLT/AH5H/wAnFxVVxV2Kqc37H+uM VVMVdiqTS+b/AC/Hz53D0jDu5EE7AJHQNJsh+DfZ/snsThpUTF5g0mW9SyjmLXMhCoojkoSYzLTl x47Iu++3Q7kY0qxPM2gukUi3sfpzcwjk0HJApZDWlG+MfCd8aVSm84eV4rZ7k6nbtFGjSEpIrEqt K8QD8XWm2NFUUdd0YXf1P67D9bq4FuHBcmMVeijfbBSpfH568qSPGi345yOsaKY5VNZEWRK1UUDI 4IY7fccNFbRFx5s8uQLKZL+INCWWSIN+8BUsCOH2j9hu2NK6TzX5cjRXOoQMHICBXBLVpuoHUb9c aVcnmjy5JKYo9St3lVQ7IsikhT3IBxpVP/F/lszNAl/FLKgUssZ50DEqPs17jfGlXyeatARYnF2J I515xSQo8qMCWAAaNWXkxjYKvUkUGNK1/irQuAc3DCs/1UIYphJ638nplOfXbpSu3XGlbPmrQRA0 31teK2xveNGDmAIXLhSAfsjGlbk80+W4gTJqdsgADEtKoHEhSD16Hmv340q4eZNBKl/r0ITk6I3M UcxqHfh/MFDCtMaVp/M/l9LhbdtQhEroJFHIEcWCkEsPhFRIpG/TfpjSrLXzX5auPWEOowFbcMZD zUDjGiuzCp3VQw36fdjStN5t8uLEZXv4lVXkjapNQ0TBXqOo41FfbfpjSqtz5k0C1WNri/hjEyrJ FycfEsgLKVHeoU40qlD5u8szCSmowKI3MTiVhH8W+1H4+BxpWh5u8um3ScXqekzrEDvUMxcLyAHw g+m258MaVdL5t8sxNxk1O3RqkFTIAQQWBBHjVDtjSr08z+Xnl9GPUYJZeYj4RuHbkzBAKLX9o40q i/nDyxHEJmv46MwWgDFyTxA+AAtT94u9Kb40quPMmgmJ5fr0QiSRoWkLUX1EQSMoY7Gimu2NKp/4 s8tUYnUrcKoDMxcBQGHIVY7dN/8AbxpW5vM+gxxJLJcfuHLcZvTkMY9ORY2LOF4qA7AVJxpW9O80 aBqMqw2d6kkzl1SIhkcmP7VFcKTSmNKmmBXUB64q7FXYqkB/wV60nH6r9Y5S+p6dPUrt61ePxU6c u2HdUVY/4Y+tL9R+q/Wfg4+jw5f3Z404/wDFdfoxVATf4C+qv631L6tzb1OXHjz9OPlX39P0/o4+ 2O6qA/5Vv6ElPqPpemvqfZ/uuKca9+PDjT29sd1R5/wf+lD/ALy/pPk9acfV5V/eUpv9rr7171x3 VZYf4K/SEX1L6n+kPUk9Phx9b1eH7z/K5cetcd1al/wT9an9T6r9Z9Q/WenL1Pi5c/f7Va47qpyf 4A4Wfq/UOHpn6ly4cfT5NXhXbjy5Y7qgtN/wH/iNvqX+9vIcacvQ9T6u9eP7HL0efL6a74d0I61/ wF6cX1b6h6fEelw4U412pTBulUb/AAR9Xt+X1L0fSP1Xlwp6Xx/Yr2+3x/2VO+O6rbj/AAP6Mn1r 6pw9cep61OXr8Phrz+Llw6fhjurbf4K4rz+q0+qtx5f8s3pty6/s+ny+jHdUI/8Ayrep5fUeq1+z 9qi8f9lSlO+O6o2P/Bn+j8PqlOcn1WnGnLinPh/seHTtTHdWpP8ABf108vqv136r2p6v1T0z9mnx cPTr0x3VLvLf/Kuv0Z/uN9D0PRk9X1f730f2vU5/Fx40pXt02wm0IyX/AAH649b6n69W+3TlX9qt e/zwbpVbj/BHrj6x9S9b0oqc+FfRofS6/s8emO6oUf8AKufTb/eDhzHPlxpzqete9evvTvTHdVXT P8FcLv6t6HD62nrc6U+sekvp8a/5HT6e9cd1Qenf8q+/Scn1T0udF6V+r15Hjx/Y5cuVP9lT9rDu qNs/8B8x9U+pc/UTj6fGvqc29OlO/PlT3rg3V2nf4I9WH6n6Hr1T0q8ufRPS+38VKcOFdqUpjuqB v/8AlXH6Km9T6v8AU+T09Kv2vQj5+jTano8K8fh8e+HdCrYf8q7+qv8AV/qvGq+vz/vfUqlPU5fH z5ceu9cd0prD/hb6jH6f1X6jxPpfZ9LhzStK/DTnwr74FU9O/wAI+pY/o76tz4v9Q9Gn2ayc+PHt X1P+G98d1TvArsVf/9k= xmp.iid:b588d3fe-842e-4fd3-8143-19ff16038c2c xmp.did:b588d3fe-842e-4fd3-8143-19ff16038c2c uuid:5D20892493BFDB11914A8590D31508C8 default xmp.iid:03a389f0-931c-4f47-98c0-9e2f9ce1448d xmp.did:03a389f0-931c-4f47-98c0-9e2f9ce1448d uuid:5D20892493BFDB11914A8590D31508C8 default saved xmp.iid:44433185-2184-4731-93c4-278700048922 2019-11-26T15:11:19+01:00 Adobe Illustrator CC 2017 (Macintosh) / saved xmp.iid:b588d3fe-842e-4fd3-8143-19ff16038c2c 2020-03-04T16:01:12+01:00 Adobe Illustrator 24.0 (Macintosh) / Print Adobe Illustrator False True 1 35.014958 14.248342 Centimeters Cyan Magenta Yellow Black Groupe de nuances par défaut 0 Blanc CMYK PROCESS 0.000000 0.000000 0.000000 0.000000 Noir CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 Rouge CMJN CMYK PROCESS 0.000000 100.000000 100.000000 0.000000 Jaune CMJN CMYK PROCESS 0.000000 0.000000 100.000000 0.000000 Vert CMJN CMYK PROCESS 100.000000 0.000000 100.000000 0.000000 Cyan CMJN CMYK PROCESS 100.000000 0.000000 0.000000 0.000000 Bleu CMJN CMYK PROCESS 100.000000 100.000000 0.000000 0.000000 Magenta CMJN CMYK PROCESS 0.000000 100.000000 0.000000 0.000000 C=15 M=100 J=90 N=10 CMYK PROCESS 15.000000 100.000000 90.000000 10.000000 C=0 M=90 J=85 N=0 CMYK PROCESS 0.000000 90.000000 85.000000 0.000000 C=0 M=80 J=95 N=0 CMYK PROCESS 0.000000 80.000000 95.000000 0.000000 C=0 M=50 J=100 N=0 CMYK PROCESS 0.000000 50.000000 100.000000 0.000000 C=0 M=35 J=85 N=0 CMYK PROCESS 0.000000 35.000000 85.000000 0.000000 C=5 M=0 J=90 N=0 CMYK PROCESS 5.000000 0.000000 90.000000 0.000000 C=20 M=0 J=100 N=0 CMYK PROCESS 20.000000 0.000000 100.000000 0.000000 C=50 M=0 J=100 N=0 CMYK PROCESS 50.000000 0.000000 100.000000 0.000000 C=75 M=0 J=100 N=0 CMYK PROCESS 75.000000 0.000000 100.000000 0.000000 C=85 M=10 J=100 N=10 CMYK PROCESS 85.000000 10.000000 100.000000 10.000000 C=90 M=30 J=95 N=30 CMYK PROCESS 90.000000 30.000000 95.000000 30.000000 C=75 M=0 J=75 N=0 CMYK PROCESS 75.000000 0.000000 75.000000 0.000000 C=80 M=10 J=45 N=0 CMYK PROCESS 80.000000 10.000000 45.000000 0.000000 C=70 M=15 J=0 N=0 CMYK PROCESS 70.000000 15.000000 0.000000 0.000000 C=85 M=50 J=0 N=0 CMYK PROCESS 85.000000 50.000000 0.000000 0.000000 C=100 M=95 J=5 N=0 CMYK PROCESS 100.000000 95.000000 5.000000 0.000000 C=100 M=100 J=25 N=25 CMYK PROCESS 100.000000 100.000000 25.000000 25.000000 C=75 M=100 J=0 N=0 CMYK PROCESS 75.000000 100.000000 0.000000 0.000000 C=50 M=100 J=0 N=0 CMYK PROCESS 50.000000 100.000000 0.000000 0.000000 C=35 M=100 J=35 N=10 CMYK PROCESS 35.000000 100.000000 35.000000 10.000000 C=10 M=100 J=50 N=0 CMYK PROCESS 10.000000 100.000000 50.000000 0.000000 C=0 M=95 J=20 N=0 CMYK PROCESS 0.000000 95.000000 20.000000 0.000000 C=25 M=25 J=40 N=0 CMYK PROCESS 25.000000 25.000000 40.000000 0.000000 C=40 M=45 J=50 N=5 CMYK PROCESS 40.000000 45.000000 50.000000 5.000000 C=50 M=50 J=60 N=25 CMYK PROCESS 50.000000 50.000000 60.000000 25.000000 C=55 M=60 J=65 N=40 CMYK PROCESS 55.000000 60.000000 65.000000 40.000000 C=25 M=40 J=65 N=0 CMYK PROCESS 25.000000 40.000000 65.000000 0.000000 C=30 M=50 J=75 N=10 CMYK PROCESS 30.000000 50.000000 75.000000 10.000000 C=35 M=60 J=80 N=25 CMYK PROCESS 35.000000 60.000000 80.000000 25.000000 C=40 M=65 J=90 N=35 CMYK PROCESS 40.000000 65.000000 90.000000 35.000000 C=40 M=70 J=100 N=50 CMYK PROCESS 40.000000 70.000000 100.000000 50.000000 C=50 M=70 J=80 N=70 CMYK PROCESS 50.000000 70.000000 80.000000 70.000000 Gris 1 C=0 M=0 J=0 N=100 CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 C=0 M=0 J=0 N=90 CMYK PROCESS 0.000000 0.000000 0.000000 89.999400 C=0 M=0 J=0 N=80 CMYK PROCESS 0.000000 0.000000 0.000000 79.998800 C=0 M=0 J=0 N=70 CMYK PROCESS 0.000000 0.000000 0.000000 69.999700 C=0 M=0 J=0 N=60 CMYK PROCESS 0.000000 0.000000 0.000000 59.999100 C=0 M=0 J=0 N=50 CMYK PROCESS 0.000000 0.000000 0.000000 50.000000 C=0 M=0 J=0 N=40 CMYK PROCESS 0.000000 0.000000 0.000000 39.999400 C=0 M=0 J=0 N=30 CMYK PROCESS 0.000000 0.000000 0.000000 29.998800 C=0 M=0 J=0 N=20 CMYK PROCESS 0.000000 0.000000 0.000000 19.999700 C=0 M=0 J=0 N=10 CMYK PROCESS 0.000000 0.000000 0.000000 9.999100 C=0 M=0 J=0 N=5 CMYK PROCESS 0.000000 0.000000 0.000000 4.998800 Couleurs vives 1 C=0 M=100 J=100 N=0 CMYK PROCESS 0.000000 100.000000 100.000000 0.000000 C=0 M=75 J=100 N=0 CMYK PROCESS 0.000000 75.000000 100.000000 0.000000 C=0 M=10 J=95 N=0 CMYK PROCESS 0.000000 10.000000 95.000000 0.000000 C=85 M=10 J=100 N=0 CMYK PROCESS 85.000000 10.000000 100.000000 0.000000 C=100 M=90 J=0 N=0 CMYK PROCESS 100.000000 90.000000 0.000000 0.000000 C=60 M=90 J=0 N=0 CMYK PROCESS 60.000000 90.000000 0.003100 0.003100 Adobe PDF library 15.00

OCS-01: A potential paradigm
shift in DME treatment

One of our most advanced product candidates, OCS-01, is in phase 2 clinical development for DME and also for Pain and inflammation following ocular surgery. The Phase 2 trial in DME (DX-211) with 144 patients was successfully completed providing the first proof-of-concept for a topical drug effect on a chronic retinal disease.

 

OCS-01 has been developed from Oculis’ solubilizing nanoparticle (SNP) technology, a proprietary platform that enables the formulation of drugs as non-invasive topical treatments and enhances their bioavailability in the relevant eye tissues. If approved in DME, it has the potential to provide a new option for patients.

OCS-01: A potential treatment
for Post-cataract Surgery Inflammation

 

Because patients undergoing cataract surgery are usually on several medications daily, adding more eye drops can be challenging. A long-acting topical solution such as OCS-01 has the potential of reducing the frequency of the burden of administration to patients.

OCS-02: THE POTENTIAL OF
topical anti-TNF alpha
therapy for ophthalmic
indications

The compound, named OCS-02, is based on a proprietary single-chain antibody fragment technology specifically designed for topical delivery. Efficacy and safety were evaluated in three clinical trials including two controlled studies under IND. The studies demonstrated a promising profile for treating inflammatory conditions of the anterior segment of the eye including Uveitis and Dry Eye Disease.